254 related articles for article (PubMed ID: 21179495)
1. Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.
Jeong Y; Xie Y; Xiao G; Behrens C; Girard L; Wistuba II; Minna JD; Mangelsdorf DJ
PLoS Med; 2010 Dec; 7(12):e1000378. PubMed ID: 21179495
[TBL] [Abstract][Full Text] [Related]
2. Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.
Jeong Y; Xie Y; Lee W; Bookout AL; Girard L; Raso G; Behrens C; Wistuba II; Gadzar AF; Minna JD; Mangelsdorf DJ
Mol Endocrinol; 2012 Aug; 26(8):1443-54. PubMed ID: 22700587
[TBL] [Abstract][Full Text] [Related]
3. Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.
Lu Y; Wang L; Liu P; Yang P; You M
PLoS One; 2012; 7(1):e30880. PubMed ID: 22292069
[TBL] [Abstract][Full Text] [Related]
4. Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer.
Sasaki H; Tanahashi M; Yukiue H; Moiriyama S; Kobayashi Y; Nakashima Y; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Lung Cancer; 2002 Apr; 36(1):71-6. PubMed ID: 11891036
[TBL] [Abstract][Full Text] [Related]
5. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
6. Research resource: nuclear receptors as transcriptome: discriminant and prognostic value in breast cancer.
Muscat GE; Eriksson NA; Byth K; Loi S; Graham D; Jindal S; Davis MJ; Clyne C; Funder JW; Simpson ER; Ragan MA; Kuczek E; Fuller PJ; Tilley WD; Leedman PJ; Clarke CL
Mol Endocrinol; 2013 Feb; 27(2):350-65. PubMed ID: 23292282
[TBL] [Abstract][Full Text] [Related]
7. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
9. Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients.
Xie Y; Xiao G; Coombes KR; Behrens C; Solis LM; Raso G; Girard L; Erickson HS; Roth J; Heymach JV; Moran C; Danenberg K; Minna JD; Wistuba II
Clin Cancer Res; 2011 Sep; 17(17):5705-14. PubMed ID: 21742808
[TBL] [Abstract][Full Text] [Related]
10. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
11. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Siegfried JM; Lin Y; Diergaarde B; Lin HM; Dacic S; Pennathur A; Weissfeld JL; Romkes M; Nukui T; Stabile LP
Neoplasia; 2015 Nov; 17(11):817-25. PubMed ID: 26678909
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
13. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
Kang MW; Lee ES; Yoon SY; Jo J; Lee J; Kim HK; Choi YS; Kim K; Shim YM; Kim J; Kim H
J Int Med Res; 2011; 39(1):78-85. PubMed ID: 21672310
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.
Guo NL; Wan YW; Tosun K; Lin H; Msiska Z; Flynn DC; Remick SC; Vallyathan V; Dowlati A; Shi X; Castranova V; Beer DG; Qian Y
Clin Cancer Res; 2008 Dec; 14(24):8213-20. PubMed ID: 19088038
[TBL] [Abstract][Full Text] [Related]
15. Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer.
Rossi G; Papotti M; Barbareschi M; Graziano P; Pelosi G
J Clin Oncol; 2009 Oct; 27(28):e141-2; author reply e143-4. PubMed ID: 19720885
[No Abstract] [Full Text] [Related]
16. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy.
Hou J; Lambers M; den Hamer B; den Bakker MA; Hoogsteden HC; Grosveld F; Hegmans J; Aerts J; Philipsen S
J Thorac Oncol; 2012 Jan; 7(1):105-14. PubMed ID: 22134068
[TBL] [Abstract][Full Text] [Related]
18. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection.
Jiang W; Pang XG; Wang Q; Shen YX; Chen XK; Xi JJ
Clin Lung Cancer; 2012 Jul; 13(4):280-7. PubMed ID: 22178381
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer prognosis predicted by nuclear receptor-coregulator networks.
Doan TB; Eriksson NA; Graham D; Funder JW; Simpson ER; Kuczek ES; Clyne C; Leedman PJ; Tilley WD; Fuller PJ; Muscat GE; Clarke CL
Mol Oncol; 2014 Jul; 8(5):998-1013. PubMed ID: 24785096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
